Intraceuticals has launched Exosomes+V and PDRN. These two advanced professional serums reflect the brand's evolution toward skin longevity and regenerative skin care. These treatments are designed to work at a cellular level and to optimize the biological signals that guide the skin's ability to repair, renew and rebuild itself naturally.
The Exosome+V serum has vegan biomimetic exosomes for enhanced cell-to-cell communication, Centella Asiatica phyto-peptidic fractions for advanced peptide support, a vitamin A, C and E complex for antioxidant protection and low molecular weight hyaluronic acid for enhanced delivery and hydration. These ingredients support collagen production, long-term skin vitality and support cellular renewal, and deliver visible improvements in radiance, firmness and overall skin quality. This treatment was developed for clients who are focused on long-term skin optimization and prevention.
The PDRN serum uses salmon-derived polynucleotides. It supports DNA synthesis and activates key anti-inflammatory pathways to help restore skin function from within. It promotes visible firmness, reduces post-procedure redness, improves the tone, texture and radiance of skin, as well as enhances collagen and elastin synthesis. It is designed for visible transformation and accelerated recovery.
The Exosomes+V and PDRN are delivered using Intraceuticals' signature hyperbaric oxygen technology and low molecular weight hyaluronic acid, which ensures optimal penetration and efficacy without the need for invasive procedures. It allows clinics to offer advanced regenerative treatments with no downtime, no needles, immediate comfort and visible results.
